# Pedro Coelho

> Pedro Coelho is the founder and CEO of Biorce, a Barcelona-based health AI company building software that designs and manages clinical trials in minutes instead of months. A Portuguese entrepreneur with over eight years in life sciences consulting, he started Biorce after a clinical trial bought his father, who was dying of melanoma, ten extra months of life. In February 2026 the company closed a $52M Series A led by DST Global, the largest Series A in Iberian healthtech and AI, backed by angels including the CEOs of Mistral, Revolut, OutSystems and Seedtag.

- **Role:** Founder & CEO at Biorce
- **Organizations:** Biorce, Talentmark (former), TMFS (former), Konspol Holding (former)
- **From:** Portugal
- **Nationality:** Portuguese
- **Education:** Business Administration (Summa Cum Laude), EU Business School, Executive education, Harvard Medical School, Executive education, University of Pennsylvania
- **Known for:** Built the first fully AI-generated clinical trial protocol, compressing an 18-month, 10-person process into minutes, Generates 100+ page trial protocols in roughly 90 seconds at about 86% accuracy, Raised the largest Series A in Iberian healthtech and AI ($52M, February 2026)

## Career timeline

- **2016** — Completes Business Administration degree (Summa Cum Laude) at EU Business School
- **Pre-2022** — Works 8+ years in life sciences consulting, clinical trials and drug development; Chief Commercial Officer at Konspol Holding
- **Pre-2022** — Senior Vice President at Talentmark; creates and leads TMFS, a CRO focused on Oncology and Cell & Gene Therapy
- **2024-01** — Conceives Biorce on a flight from Lisbon to San Francisco en route to the JPM Health Conference
- **2024** — Founds Biorce in Barcelona with Clara Bernardes, Jose Faria and Diogo Pisoeiro
- **2024-11** — Raises EUR 3.5M round led by YZR Capital and Mustard Seed Maze
- **2025-07** — Raises EUR 5M round from Norrsken VC
- **2026-02** — Closes $52M Series A led by DST Global, largest Series A in Iberian healthtech and AI

## Achievements

- Built the first fully AI-generated clinical trial protocol, compressing an 18-month, 10-person process into minutes
- Generates 100+ page trial protocols in roughly 90 seconds at about 86% accuracy
- Raised the largest Series A in Iberian healthtech and AI ($52M, February 2026)
- Attracted angels including Arthur Mensch (Mistral), Nik Storonsky (Revolut), Paulo Rosado (OutSystems) and Albert Nieto (Seedtag)
- Grew Biorce to ~130 employees across Europe and the US
- Built Biorce's AI on a proprietary database of 530,000+ annotated clinical studies
- Ranked top 2% globally in the International Baccalaureate in Sciences

## Latest updates

- **2026-02** — Closed a $52M Series A led by DST Global; opening an Austin, Texas office and scaling engineering and commercial teams.
- **2025-07** — Raised EUR 5M from Norrsken VC to expand in the US.
- **2024-11** — Raised EUR 3.5M led by YZR Capital and Mustard Seed Maze.

## Links

- Website: https://biorce.com
- LinkedIn: http://www.linkedin.com/in/pmfccoelho

---

Profile page: https://yespress.io/pedro-coelho
Published by YesPress — https://yespress.io
Last updated: 2026-06-08